Showing results (551-560 of 734) with videos related to
Sort By:
Pageof 74
Blood|February 4, 2016
Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institutionSaad Sirop Kenderian, Thomas M Habermann, William R Macon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Phase II trial of the oral mammalian target of rapamycin inhibitor everolimus in relapsed or refractory Waldenstrom macroglobulinemiaIrene M Ghobrial, Morie Gertz, Betsy Laplant, et al.Blood|April 30, 2015
The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphomaThomas E Witzig, Craig Reeder, Jing Jing Han, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2019
Late Relapses in Patients With Diffuse Large B-Cell Lymphoma Treated With ImmunochemotherapyYucai Wang, Umar Farooq, Brian K Link, et al.Seminars in Hematology|May 17, 2025
Report of Consensus Panel 6 from the 12th International Workshop on Waldenström's Macroglobulinemia on Diagnosis and Management of Transformed Waldenström's MacroglobulinemiaEric Durot, Jithma P Abeykoon, Damien Roos-Weil, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2019
Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II StudyStephen M Ansell, Monique C Minnema, Peter Johnson, et al.Blood|December 8, 2018
Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter studyJorge J Castillo, Gilad Itchaki, Jonas Paludo, et al.Blood|July 20, 2016
Treatment recommendations from the Eighth International Workshop on Waldenström's MacroglobulinemiaVéronique Leblond, Efstathios Kastritis, Ranjana Advani, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 24, 2026
No association of prior administration of selected vaccines with lymphoma prognosisGeorge A Cholack, Verena Hinder, Raphael Mwangi, et al.International Journal of Radiation Oncology, Biology, Physics|October 16, 2025
The Role of Radiation Therapy in the Management of Gray Zone LymphomaOmran Saifi, Scott C Lester, Nadia Laack, et al.Pageof 74